Pecorino: Molecular Biology of Cancer 2e
Chapter 13
Further reading
Antonia, S., Mule, J.J., and Weber, J.S. (2004) Current developments of immunotherapy in the clinic. Curr. Opin. Immunol. 16: 130-136. [PubMed: 15023403] [DOI: 10.1016/j.coi.2004.01.012]
Blattman, J.N. and Greenberg, P.D. (2004) Cancer immunotherapy: a treatment for the masses. Science 305: 200-205. [PubMed: 15247469] [DOI: 10.1126/science.1100369]
Chang, J.C., Hilsenbeck, S.G., and Fuqua, S.A.W. (2005) Utility of microarrays in the management of breast cancer patients. Drug Discov. Today: Ther. Strategies 2: 307-311. [DOI: 10.1016/j.ddstr.2005.11.006]
Dalton, W.S. and Friend, S.H. (2006) Cancer biomarkers - an invitation to the table. Science 312: 1165-1168. [PubMed: 16728629] [DOI: 10.1126/science.1125948]
Ferrari, M. (2005) Cancer nanotechnology: opportunities and challenges. Nature Rev. Cancer 5: 161-171. [DOI: 10.1038/nrc1566]
Figdor, C.G., de Vries, I.J., Lesterhuis, W.J., and Melief, C.J.M. (2004) Dendritic cell immunotherapy: mapping the way. Nature Med. 10: 475-480. [PubMed: 15122249] [DOI: 10.1038/nm1039]
Finn, O.J. (2003) Cancer vaccines: between the idea and the reality. Nature Rev. Immunol. 3: 630-641. [DOI: 10.1038/nri1150]
Finn, O.J. and Forni, G. (2002) Prophylactic cancer vaccines. Curr. Opin. Immunol. 14: 172-177. [PubMed: 11869888] [DOI: 10.1016/S0952-7915(02)00317-5]
Frazer, I.H. (2004) Prevention of cervical cancer through papillomavirus vaccination. Nature Rev. Immunol. 4: 46-54. [DOI: 10.1038/nri1260]
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., and Thun, M.J. (2007) Cancer Statistics, 2007. CA Cancer J. Clin. 57: 43-66. [PubMed: 17237035]
Lollini, P.-L., Cavallo, F., Nanni, P., and Forni, G. (2006) Vaccines for tumour prevention. Nature Rev. Cancer 6: 204-216. [DOI: 10.1038/nrc1815]
Liu, E.T. (2003) Classification of cancers by expression profiling. Curr. Opin. Genet. Dev. 13: 97-103. [PubMed: 12573442] [DOI: 10.1016/S0959-437X(03)00008-X]
Schuler, G., Schuler-Thurner, B., and Steinman, R.M. (2003) The use of dendritic cells in cancer immunotherapy. Curr. Opin. Immunol. 15: 138-147. [PubMed: 12633662] [DOI: 10.1016/S0952-7915(03)00015-3]
Weissleder, R. (2006) Molecular imaging in cancer. Science 312: 1168-1171. [PubMed: 16728630] [DOI: 10.1126/science.1125949]
Zeh, H.J., III, Stavely-O'Carroll, K., and Choti, M.A. (2001) Vaccines for colorectal cancer. Trends Mol. Med. 7: 307-313. [DOI: 10.1016/S1471-4914(01)01992-X]
Selected Special Topics
Alizadeh, A.A., Eisen, M.B., Davis, R.E., Ma, C., Lossos, I.S., Rosenwald, A., Boldrick, J.C., Sabet, H., Tran, T., Yu, X., Powell, J.I., Yang, L., Marti, G.E., Moore, T., Hudson, J., Jr, Lu, L., Lewis, D.B., Tibshirani, R., Sherlock, G., Chan, W.C., Greiner, T.C., Weisenburger, D.D., Armitage, J.O., Warnke, R., Levy, R., Wilson, W., Grever, M.R., Byrd, J.C., Botstein, D., Brown, P.O., and Staudt, L.M. (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403: 503-511. [PubMed: 10676951] [DOI: 10.1038/35000501]
Dudley, M.E., Wunderlich, J.R., Robbins, P.F., Yang, J.C., Hwu, P., Schwartzentruber, D.J., Topalian, S.L., Sherry, R., Restifo, N.P., Hubicki, A.M., Robinson, M.R., Raffeld, M., Duray, P., Seipp, C.A., Rogers-Freezer, L., Morton, K.E., Mavroukakis, S.A., White, D.E., and Rosenberg, S.A. (2002) Cancer regression and autoimmunity in patients after clonal repopulation with anti-tumor lymphocytes. Science 298: 850-854. [PubMed: 12242449] [DOI: 10.1126/science.1076514]
Glunde, K., Pathak, A.P., and Bhujwalla, Z.M. (2007) Molecular-functional imaging of cancer: to image and imagine. Trends Mol. Med. 13: 287-297. [PubMed: 17544849] [DOI: 10.1016/j.molmed.2007.05.002]
Hessels, D., Klein Gunnewiek, J.M.T., van Oort, I., Karthaus, H.F.M., van Leenders, G.J.L., van Balken, B., Kiemeney, L.A., Witjes, and J.A., and Schalken, J.A. (2003) DD3PCA3-based molecular urine analysis for the diagnosis of prostate cancer. Eur. Urol. 44: 8-16. [PubMed: 12814669] [DOI: 10.1016/S0302-2838(03)00201-X]
Palmisano, W.A., Divine, K.K., Saccomanno, G., Gilliland, F.D., Baylin, S.B., Herman, J.G., and Belinsky, S.A. (2000) Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res. 60: 5954-5958. [PubMed: 11085511]
Ramaswamy, S., Tamayo, P., Rifkin, R., Mukherjee, S., Yeang, C.-H., Angelo, M., Ladd, C., Reich, M., Latulippe, E., Mesirov, J.P., Poggio, T., Gerald, W., Loda, M., Lander, E.S., and Golub, T.R. (2001) Multiclass cancer diagnosis using tumor gene expression signatures. Proc. Natl. Acad. Sci. USA 98: 15149-15154. [PubMed: 11742071] [DOI: 10.1073/pnas.211566398]
Rosenberg, S.A. (2001) Progress in human tumor immunology and immunotherapy. Nature 411: 380-384. [PubMed: 11357146] [DOI: 10.1038/35077246]
Shipp, M.A., Ross, K.N., Tamayo, P., Weng, A.P., Kutok, J.L., Aguiar, R.C.T., Gaasenbeek, M., Angelo, M., Reich, M., Pinkus, G.S., Ray, T.S., Koval, M.A., Last, K.W., Norton, A., Lister, A., Mesirov, J., Neuberg, D.S., Lander, E.S., Aster, J.C., and Golub, T.R. (2002) Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nature Med. 8: 68-74. [PubMed: 11786909] [DOI: 10.1038/nm0102-68]
Tisdale, M.J. (2002) Cachexia in cancer patients. Nature Rev. Cancer 2: 862-870. [DOI: 10.1038/nrc927]
Van't Veer, L.J., Dai, H., van de Vijver, M.J., He, Y.D., Hart, A.A.M., Mao, M., Peterse, H.L., van der Kooy, K., Marton, M.J., Witteveen, A.T., Schreiber, G.J., Kerkhoven, R.M., Roberts, C., Linsley, P.S., Bernards, R., and Friend, S.H. (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415: 530-535. [DOI: 10.1038/415530a]


